Symbol:
Ypel2
Name:
yippee like 2
RGD ID:
1551032
MGI Page
MGI
Description:
Predicted to enable metal ion binding activity. Predicted to be located in nucleolus. Is expressed in forebrain and lens vesicle. Orthologous to human YPEL2 (yippee like 2).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
6430570G24; E130113K08Rik; ortholog of human yippee-like 2 YPEL2; protein yippee-like 2; RP23-188E9.1; yippee-like 2 (Drosophila)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
YPEL2 (yippee like 2)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Ypel2 (yippee-like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ypel2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
YPEL2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
YPEL2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ypel2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
YPEL2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
YPEL2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ypel2 (yippee like 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
YPEL2 (yippee like 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ypel2b (yippee-like 2b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|SonicParanoid|ZFIN)
Danio rerio (zebrafish):
ypel2a (yippee-like 2a)
Alliance
DIOPT (OMA|PANTHER|ZFIN)
Drosophila melanogaster (fruit fly):
CG15309
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
F37A8.5
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
MOH1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoInspector|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
ypel2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 86,827,251 - 86,884,629 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 86,827,251 - 86,884,533 (-) Ensembl GRCm39 Ensembl GRCm38 11 86,936,425 - 86,993,805 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 86,936,425 - 86,993,707 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 86,749,927 - 86,807,264 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 86,756,775 - 86,788,204 (-) NCBI MGSCv36 mm8 Celera 11 96,537,509 - 96,595,109 (-) NCBI Celera Cytogenetic Map 11 C NCBI cM Map 11 51.82 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ypel2 Mouse 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of YPEL2 mRNA CTD PMID:26682919 Ypel2 Mouse 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of YPEL2 mRNA CTD PMID:28960355 Ypel2 Mouse 17beta-estradiol affects expression ISO YPEL2 (Homo sapiens) 6480464 Estradiol affects the expression of YPEL2 mRNA CTD PMID:22574217 Ypel2 Mouse 17beta-estradiol decreases expression ISO YPEL2 (Homo sapiens) 6480464 Estradiol results in decreased expression of YPEL2 mRNA CTD PMID:31614463 Ypel2 Mouse 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of YPEL2 mRNA CTD PMID:39298647 Ypel2 Mouse 17beta-estradiol decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of YPEL2 mRNA CTD PMID:32145629 Ypel2 Mouse 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO YPEL2 (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 Ypel2 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of YPEL2 mRNA CTD PMID:25975270 Ypel2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of YPEL2 mRNA CTD PMID:33387578 Ypel2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of YPEL2 mRNA CTD PMID:33956508 Ypel2 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of YPEL2 mRNA CTD PMID:28922406 Ypel2 Mouse 2-hydroxypropanoic acid decreases expression ISO YPEL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of YPEL2 mRNA CTD PMID:30851411 Ypel2 Mouse 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL2 mRNA CTD PMID:28628672 Ypel2 Mouse 4,4'-sulfonyldiphenol affects expression EXP 6480464 bisphenol S affects the expression of YPEL2 mRNA CTD PMID:39298647 Ypel2 Mouse 5-aza-2'-deoxycytidine multiple interactions ISO YPEL2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of YPEL2 mRNA] CTD PMID:21095227 Ypel2 Mouse 6-propyl-2-thiouracil decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of YPEL2 mRNA CTD PMID:30047161 Ypel2 Mouse acetamide decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 acetamide results in decreased expression of YPEL2 mRNA CTD PMID:31881176 Ypel2 Mouse acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of YPEL2 mRNA CTD PMID:30807115 Ypel2 Mouse acrylamide increases expression ISO YPEL2 (Homo sapiens) 6480464 Acrylamide results in increased expression of YPEL2 mRNA CTD PMID:32763439 Ypel2 Mouse aflatoxin B1 decreases methylation ISO YPEL2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of YPEL2 gene CTD PMID:27153756 Ypel2 Mouse all-trans-retinoic acid increases expression ISO YPEL2 (Homo sapiens) 6480464 Tretinoin results in increased expression of YPEL2 mRNA CTD PMID:23724009 Ypel2 Mouse amitrole decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of YPEL2 mRNA CTD PMID:30047161 Ypel2 Mouse arsane multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of YPEL2 mRNA CTD PMID:32525701 Ypel2 Mouse arsenic atom multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of YPEL2 mRNA CTD PMID:32525701 Ypel2 Mouse arsenite(3-) multiple interactions ISO YPEL2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to YPEL2 mRNA] CTD PMID:32406909 Ypel2 Mouse atrazine increases expression ISO YPEL2 (Homo sapiens) 6480464 Atrazine results in increased expression of YPEL2 mRNA CTD PMID:22378314 Ypel2 Mouse atrazine affects methylation ISO Ypel2 (Rattus norvegicus) 6480464 Atrazine affects the methylation of YPEL2 gene CTD PMID:35440735 Ypel2 Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of YPEL2 mRNA CTD PMID:19770486 Ypel2 Mouse benzo[a]pyrene decreases methylation ISO YPEL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of YPEL2 5' UTR CTD PMID:27901495 Ypel2 Mouse benzo[a]pyrene decreases expression ISO YPEL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of YPEL2 mRNA CTD PMID:26238291 Ypel2 Mouse benzo[a]pyrene diol epoxide I affects expression ISO YPEL2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Ypel2 Mouse bisphenol A affects expression ISO Ypel2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of YPEL2 mRNA CTD PMID:25181051 and PMID:32145629 Ypel2 Mouse bisphenol A increases expression ISO YPEL2 (Homo sapiens) 6480464 bisphenol A results in increased expression of YPEL2 mRNA CTD PMID:29275510 Ypel2 Mouse bisphenol F multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL2 mRNA CTD PMID:28628672 Ypel2 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of YPEL2 mRNA CTD PMID:25554681 Ypel2 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of YPEL2 mRNA CTD PMID:25620056 Ypel2 Mouse chlordecone multiple interactions EXP 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to YPEL2 gene] CTD PMID:31084621 Ypel2 Mouse cisplatin multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of YPEL2 mRNA CTD PMID:27392435 Ypel2 Mouse clothianidin increases expression ISO YPEL2 (Homo sapiens) 6480464 clothianidin results in increased expression of YPEL2 mRNA CTD PMID:31626844 Ypel2 Mouse coumestrol multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Ypel2 Mouse coumestrol decreases expression ISO YPEL2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of YPEL2 mRNA CTD PMID:19167446 Ypel2 Mouse crotonaldehyde increases expression ISO YPEL2 (Homo sapiens) 6480464 2-butenal results in increased expression of YPEL2 mRNA CTD PMID:20471460 Ypel2 Mouse cyclosporin A decreases expression ISO YPEL2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of YPEL2 mRNA CTD PMID:27989131 Ypel2 Mouse dexamethasone multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL2 mRNA CTD PMID:28628672 Ypel2 Mouse Dibutyl phosphate affects expression ISO YPEL2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of YPEL2 mRNA CTD PMID:37042841 Ypel2 Mouse dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of YPEL2 mRNA CTD PMID:24205000 Ypel2 Mouse dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of YPEL2 mRNA CTD PMID:30529165 Ypel2 Mouse dorsomorphin multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ypel2 Mouse Enterolactone multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA CTD PMID:19167446 Ypel2 Mouse entinostat decreases expression ISO YPEL2 (Homo sapiens) 6480464 entinostat results in decreased expression of YPEL2 mRNA CTD PMID:26272509 Ypel2 Mouse entinostat multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YPEL2 mRNA CTD PMID:27188386 Ypel2 Mouse epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of YPEL2 mRNA CTD PMID:35436446 Ypel2 Mouse ethyl methanesulfonate increases expression ISO YPEL2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of YPEL2 mRNA CTD PMID:23649840 Ypel2 Mouse fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of YPEL2 mRNA CTD PMID:28329830 Ypel2 Mouse flutamide increases expression ISO Ypel2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of YPEL2 mRNA CTD PMID:24793618 Ypel2 Mouse formaldehyde increases expression ISO YPEL2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of YPEL2 mRNA CTD PMID:23649840 Ypel2 Mouse gentamycin increases expression ISO Ypel2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of YPEL2 mRNA CTD PMID:33387578 Ypel2 Mouse indometacin multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL2 mRNA CTD PMID:28628672 Ypel2 Mouse isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of YPEL2 mRNA CTD PMID:20003209 Ypel2 Mouse leflunomide increases expression ISO YPEL2 (Homo sapiens) 6480464 leflunomide results in increased expression of YPEL2 mRNA CTD PMID:28988120 Ypel2 Mouse melphalan decreases expression ISO YPEL2 (Homo sapiens) 6480464 Melphalan results in decreased expression of YPEL2 mRNA CTD PMID:22363485 Ypel2 Mouse metformin decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Metformin results in decreased expression of YPEL2 mRNA CTD PMID:31324951 Ypel2 Mouse methimazole decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of YPEL2 mRNA CTD PMID:30047161 Ypel2 Mouse methyl methanesulfonate increases expression ISO YPEL2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of YPEL2 mRNA CTD PMID:23649840 Ypel2 Mouse methylmercury chloride decreases expression ISO YPEL2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of YPEL2 mRNA CTD PMID:28001369 Ypel2 Mouse methylparaben increases expression ISO YPEL2 (Homo sapiens) 6480464 methylparaben results in increased expression of YPEL2 mRNA CTD PMID:31745603 Ypel2 Mouse Nutlin-3 increases expression ISO YPEL2 (Homo sapiens) 6480464 nutlin 3 results in increased expression of YPEL2 mRNA CTD PMID:38460933 Ypel2 Mouse paracetamol decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of YPEL2 mRNA CTD PMID:33387578 Ypel2 Mouse phenethyl isothiocyanate increases expression ISO YPEL2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in increased expression of YPEL2 mRNA CTD PMID:26678675 Ypel2 Mouse phenformin decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Phenformin results in decreased expression of YPEL2 mRNA CTD PMID:31324951 Ypel2 Mouse phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of YPEL2 mRNA CTD PMID:19270015 Ypel2 Mouse pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of YPEL2 mRNA CTD PMID:28903501 Ypel2 Mouse quercetin decreases expression ISO YPEL2 (Homo sapiens) 6480464 Quercetin results in decreased expression of YPEL2 mRNA CTD PMID:21632981 Ypel2 Mouse rac-lactic acid decreases expression ISO YPEL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of YPEL2 mRNA CTD PMID:30851411 Ypel2 Mouse resveratrol multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of YPEL2 mRNA CTD PMID:19167446 Ypel2 Mouse rotenone decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Rotenone results in decreased expression of YPEL2 mRNA CTD PMID:28374803 Ypel2 Mouse rotenone increases expression EXP 6480464 Rotenone results in increased expression of YPEL2 mRNA CTD PMID:32937126 Ypel2 Mouse S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO YPEL2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of YPEL2 mRNA CTD PMID:33725128 Ypel2 Mouse SB 431542 multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ypel2 Mouse silicon dioxide decreases expression ISO YPEL2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of YPEL2 mRNA CTD PMID:25895662 Ypel2 Mouse silver atom increases expression ISO YPEL2 (Homo sapiens) 6480464 Silver results in increased expression of YPEL2 mRNA CTD PMID:26014281 Ypel2 Mouse silver(0) increases expression ISO YPEL2 (Homo sapiens) 6480464 Silver results in increased expression of YPEL2 mRNA CTD PMID:26014281 Ypel2 Mouse sodium arsenate multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of YPEL2 mRNA CTD PMID:32525701 Ypel2 Mouse sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of YPEL2 mRNA CTD PMID:21795629 Ypel2 Mouse sulfadimethoxine decreases expression ISO Ypel2 (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of YPEL2 mRNA CTD PMID:30047161 Ypel2 Mouse sunitinib decreases expression ISO YPEL2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of YPEL2 mRNA CTD PMID:31533062 Ypel2 Mouse thioacetamide increases expression ISO Ypel2 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of YPEL2 mRNA CTD PMID:34492290 Ypel2 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of YPEL2 mRNA CTD PMID:29264374 Ypel2 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of YPEL2 gene CTD PMID:35295148 Ypel2 Mouse tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of YPEL2 mRNA CTD PMID:31939706 Ypel2 Mouse trichostatin A decreases expression ISO YPEL2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of YPEL2 mRNA CTD PMID:24935251 and PMID:26272509 Ypel2 Mouse trichostatin A affects expression ISO YPEL2 (Homo sapiens) 6480464 trichostatin A affects the expression of YPEL2 mRNA CTD PMID:28542535 Ypel2 Mouse trichostatin A multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YPEL2 mRNA CTD PMID:27188386 Ypel2 Mouse urethane increases expression ISO YPEL2 (Homo sapiens) 6480464 Urethane results in increased expression of YPEL2 mRNA CTD PMID:28818685 Ypel2 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of YPEL2 mRNA CTD PMID:17963808 Ypel2 Mouse valproic acid decreases methylation ISO YPEL2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of YPEL2 gene CTD PMID:29154799 Ypel2 Mouse valproic acid increases expression ISO YPEL2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of YPEL2 mRNA CTD PMID:23527032 Ypel2 Mouse valproic acid affects expression ISO YPEL2 (Homo sapiens) 6480464 Valproic Acid affects the expression of YPEL2 mRNA CTD PMID:25979313 Ypel2 Mouse valproic acid decreases expression ISO YPEL2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of YPEL2 mRNA CTD PMID:23179753 more ... Ypel2 Mouse valproic acid multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YPEL2 mRNA CTD PMID:27188386 Ypel2 Mouse vinclozolin increases methylation ISO Ypel2 (Rattus norvegicus) 6480464 vinclozolin results in increased methylation of YPEL2 gene CTD PMID:31682807 Ypel2 Mouse vorinostat multiple interactions ISO YPEL2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YPEL2 mRNA CTD PMID:27188386 Ypel2 Mouse vorinostat decreases expression ISO YPEL2 (Homo sapiens) 6480464 vorinostat results in decreased expression of YPEL2 mRNA CTD PMID:26272509
1,1-dichloroethene (EXP) 1,2-dichloroethane (EXP) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-hydroxypropanoic acid (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (EXP) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (ISO) acetamide (ISO) acrylamide (EXP,ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amitrole (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) atrazine (ISO) benzo[a]pyrene (EXP,ISO) benzo[a]pyrene diol epoxide I (ISO) bisphenol A (ISO) bisphenol F (ISO) carbon nanotube (EXP) chlordecone (EXP) cisplatin (ISO) clothianidin (ISO) coumestrol (ISO) crotonaldehyde (ISO) cyclosporin A (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dioxygen (EXP) dorsomorphin (ISO) Enterolactone (ISO) entinostat (ISO) epoxiconazole (EXP) ethyl methanesulfonate (ISO) fluoranthene (EXP) flutamide (ISO) formaldehyde (ISO) gentamycin (ISO) indometacin (ISO) isoprenaline (EXP) leflunomide (ISO) melphalan (ISO) metformin (ISO) methimazole (ISO) methyl methanesulfonate (ISO) methylmercury chloride (ISO) methylparaben (ISO) Nutlin-3 (ISO) paracetamol (ISO) phenethyl isothiocyanate (ISO) phenformin (ISO) phenobarbital (EXP) pregnenolone 16alpha-carbonitrile (EXP) quercetin (ISO) rac-lactic acid (ISO) resveratrol (ISO) rotenone (EXP,ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenate (EXP,ISO) sulfadimethoxine (ISO) sunitinib (ISO) thioacetamide (ISO) titanium dioxide (EXP) tributylstannane (EXP) trichostatin A (ISO) urethane (ISO) valproic acid (EXP,ISO) vinclozolin (ISO) vorinostat (ISO)
Ypel2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 86,827,251 - 86,884,629 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 86,827,251 - 86,884,533 (-) Ensembl GRCm39 Ensembl GRCm38 11 86,936,425 - 86,993,805 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 86,936,425 - 86,993,707 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 86,749,927 - 86,807,264 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 86,756,775 - 86,788,204 (-) NCBI MGSCv36 mm8 Celera 11 96,537,509 - 96,595,109 (-) NCBI Celera Cytogenetic Map 11 C NCBI cM Map 11 51.82 NCBI
YPEL2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 59,331,655 - 59,401,729 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 59,331,655 - 59,401,729 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 57,409,016 - 57,479,090 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 54,763,835 - 54,833,877 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 17 53,871,908 - 53,941,133 (+) NCBI Celera Cytogenetic Map 17 q22 NCBI HuRef 17 52,768,378 - 52,838,196 (+) NCBI HuRef CHM1_1 17 57,474,446 - 57,544,454 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 60,199,794 - 60,269,870 (+) NCBI T2T-CHM13v2.0
Ypel2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 72,243,591 - 72,301,124 (-) NCBI GRCr8 mRatBN7.2 10 71,746,308 - 71,803,843 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 71,746,311 - 71,803,911 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 76,356,800 - 76,414,359 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 75,861,684 - 75,919,248 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 71,326,222 - 71,383,781 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 74,241,032 - 74,298,691 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 74,243,812 - 74,298,599 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 75,804,187 - 75,861,077 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 75,209,773 - 75,263,943 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 75,225,122 - 75,278,313 (-) NCBI Celera 10 70,665,388 - 70,719,806 (-) NCBI Celera Cytogenetic Map 10 q26 NCBI
Ypel2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955451 3,641,887 - 3,704,658 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955451 3,644,951 - 3,698,658 (-) NCBI ChiLan1.0 ChiLan1.0
YPEL2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 75,496,773 - 75,566,570 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 80,308,027 - 80,377,948 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 53,400,950 - 53,470,434 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 58,246,304 - 58,316,099 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 58,246,304 - 58,316,099 (+) Ensembl panpan1.1 panPan2
YPEL2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 33,872,730 - 33,935,877 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 33,872,797 - 33,931,236 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 33,105,666 - 33,168,843 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 34,677,620 - 34,744,956 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 34,677,646 - 34,743,895 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 33,465,822 - 33,528,958 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 33,752,270 - 33,815,185 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 33,839,051 - 33,902,169 (+) NCBI UU_Cfam_GSD_1.0
Ypel2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 33,114,068 - 33,175,192 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936490 3,899,866 - 3,939,311 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936490 3,899,488 - 3,961,234 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
YPEL2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 35,573,495 - 35,644,199 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 35,573,148 - 35,644,204 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 36,808,780 - 36,883,481 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
YPEL2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 34,042,597 - 34,106,735 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 34,042,551 - 34,086,816 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666077 4,838,161 - 4,902,963 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ypel2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2110 Count of miRNA genes: 774 Interacting mature miRNAs: 1060 Transcripts: ENSMUST00000018571 Prediction methods: Microtar, Miranda, Targetscan Result types: miRGate_prediction
27226783 Tibl5_m tibia length 5, 5 week (mouse) 11 68190826 101890826 Mouse 1300628 Lgth6_m body length 6 (mouse) Not determined 11 66733420 100733652 Mouse 4141367 Inf1_m acute ozone induced inflammation (mouse) Not determined 44630038 113058009 Mouse 1558812 Rafar_m retinoic acid induced forelimb autopod reduction (mouse) Not determined 11 70691198 104691366 Mouse 1300766 Skull16_m skull morphology 16 (mouse) Not determined 11 81574481 115574636 Mouse 1301404 Sbmd4_m spinal bone mineral density 4 (mouse) Not determined 11 72019649 106019734 Mouse 4142121 Tmc1m2_m Tmc1 modifier 2 (mouse) Not determined 11 56864027 114157957 Mouse 27226758 Femd3_m femur midshaft diameter 3, 5 week (mouse) 11 80890826 101890826 Mouse 14747003 Mancz9_m mandible centroid size 9 (mouse) 11 85844911 119844911 Mouse 1301640 Lore4_m loss of righting induced by ethanol 4 (mouse) Not determined 11 79156009 107616472 Mouse 10412288 Carg4_m Candida albicans resistance gene 4 (mouse) Not determined 11 81810267 115810267 Mouse 1357878 Mastr_m modifier of astrocytoma (mouse) Not determined 11 45708581 89818733 Mouse 1301681 Sle13_m systematic lupus erythematosus susceptibility 13 (mouse) Not determined 11 70691198 104691366 Mouse 1300784 Prdt3_m prion disease incubation time 3 (mouse) Not determined 11 66733420 100733652 Mouse 4141339 Nilac2_m nicotine induced locomotor activity 2 (mouse) Not determined 11 70691198 104691366 Mouse 10413882 Moe1_m modifier of epilepsy 1 (mouse) 11 77770978 111771099 Mouse 11039501 Ltpr6a_m Leishmania tropica response 6a (mouse) 11 64830336 98830473 Mouse 13208559 Wght10_m weight 10 (mouse) 11 3950000 88890826 Mouse 11039502 Ltpr6b_m Leishmania tropica response 6b (mouse) 11 64830336 98830473 Mouse 13208558 Lgth12_m body length 12 (mouse) 11 3950000 94890826 Mouse 10045616 Heal25_m wound healing/regeneration 25 (mouse) Not determined 11 77437183 111437322 Mouse 1300664 Etohcta9_m ethanol conditioned taste aversion 9 (mouse) Not determined 11 57754660 91754758 Mouse 1301310 Tmevd5_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 5 (mouse) Not determined 11 72726125 106726289 Mouse 1300924 Ity2_m immunity to S. typhimurium 2 (mouse) Not determined 1 58508030 87695238 Mouse 11039515 Ltpr6_m Leishmania tropica response 6 (mouse) 11 64830336 98830473 Mouse 4142348 Pstc2_m periosteal circumference 2 (mouse) Not determined 11 72818615 106818733 Mouse 1300774 Pgia7_m proteoglycan induced arthritis 7 (mouse) Not determined 11 53390588 87390737 Mouse 1301414 Heal10_m wound healing/regeneration 10 (mouse) Not determined 11 77437183 111437322 Mouse 15092049 Wsigrme3_m week six growth rate, maternal effect 3 (mouse) 11 84877324 96629512 Mouse 1300651 Pcyts3_m plasmacytoma susceptibility 3 (mouse) Not determined 11 70691198 104691366 Mouse 1301546 Pcir2_m periosteal circumference 2 (mouse) Not determined 11 66733420 100733652 Mouse 1300905 Scc6_m colon tumor susceptibility 6 (mouse) Not determined 11 6880277 89019734 Mouse 1300649 Crhq1_m compensatory renal hypertrophy QTL 1 (mouse) Not determined 11 81574481 115574636 Mouse 14746970 Manh71_m mandible shape 71 (mouse) 11 79416257 113416257 Mouse 15092057 Lgrme3_m late growth rate, maternal effect 3 (mouse) 11 84877324 96629512 Mouse 10043865 T2dm5sa_m type 2 diabetes mellitus 5 in SMXA RI mice (mouse) Not determined 11 79813759 104502698 Mouse 39128214 Lwq20_m liver weight QTL 20 (mouse) 11 12268637 118022724 Mouse 10043866 Adip19_m adiposity 19 (mouse) Not determined 11 72818615 106818733 Mouse 1301072 Eae22_m experimental allergic encephalomyelitis 22 (mouse) Not determined 11 82377698 116377820 Mouse 10412246 Dfs2_m dental fluorosis suseptibility 2 (mouse) Not determined 11 21807364 95881231 Mouse 11038695 Par8_m pulmonary adenoma resistance 8 (mouse) 11 77063779 111063918 Mouse 1357766 Si5lq6_m serum IGFBP-5 level QTL 6 (mouse) Not determined 11 66733420 100733652 Mouse 1301319 Dautb4_m dopamine uptake transporter binding 4 (mouse) Not determined 11 62156005 96156153 Mouse 1301833 Tbbmd5_m total body bone mineral density 5 (mouse) Not determined 11 66733420 100733652 Mouse 15014785 Mvlq1_m macrovesicular liver lesion QTL 1 (mouse) 11 86608320 120608320 Mouse 4141012 Femwf6_m femur work to failure 6 (mouse) Not determined 66733420 100733652 Mouse 15039374 Adip29_m adiposity 29 (mouse) 11 86608320 120608320 Mouse 1301987 Pid3_m prior incubation determinant 3 (mouse) Not determined 11 61686820 88699728 Mouse 27226730 Tibmd1_m tibia midshaft diameter 1, 5 week (mouse) 11 62590826 109390826 Mouse 15039376 Bw42_m body weight QTL 42 (mouse) 11 86608320 120608320 Mouse 4141894 Nidd6k_m Nidd6 on KK-A (mouse) Not determined 19124204 96897826 Mouse 10044004 Stzid3_m streptozotocin induced diabetes susceptibility 3 (mouse) Not determined 11 63319407 94063918 Mouse 1302124 Eae7_m susceptibility to experimental allergic encephalomyelitis 7 (mouse) Not determined 11 77573873 99377820 Mouse
AU022823
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 11 86,950,599 - 86,950,801 UniSTS GRCm38 MGSCv37 11 86,764,101 - 86,764,303 UniSTS GRCm37 Celera 11 96,551,693 - 96,551,895 UniSTS Cytogenetic Map 11 C UniSTS Whitehead/MRC_RH 11 1113.39 UniSTS
UniSTS:236685
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 11 86,950,272 - 86,950,431 UniSTS GRCm38 MGSCv37 11 86,763,774 - 86,763,933 UniSTS GRCm37 Celera 11 96,551,366 - 96,551,525 UniSTS Cytogenetic Map 11 C UniSTS
Grik1
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 11 C UniSTS Cytogenetic Map 16 C3.3 UniSTS Cytogenetic Map 15 B3 UniSTS Cytogenetic Map 16 B3 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000018571 ⟹ ENSMUSP00000018571
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 11 86,827,251 - 86,884,533 (-) Ensembl GRCm38.p6 Ensembl 11 86,936,425 - 86,993,707 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000238921 ⟹ ENSMUSP00000158888
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 11 86,831,425 - 86,862,850 (-) Ensembl GRCm38.p6 Ensembl 11 86,940,599 - 86,972,024 (-) Ensembl
RefSeq Acc Id:
NM_001005341 ⟹ NP_001005341
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 11 86,827,251 - 86,884,588 (-) NCBI GRCm38 11 86,936,425 - 86,993,762 (-) NCBI MGSCv37 11 86,749,927 - 86,807,264 (-) RGD Celera 11 96,537,509 - 96,595,109 (-) RGD cM Map 11 ENTREZGENE
Sequence:
GGCAAGCCCCCAGCCCGGATTCGGAGGGATGCGGAGCGGCAGTGGCGGCGGCGGTGGCGGAGACTGTGGCTTTAAGAGCGCGCAGGGAGCGCTAGAGTCAGCCGTGCAGTCCTTCATCGCCAAGCACT CCGGAGAGCCCGGCGCTGGCCGGACCGGGCAGCCTACCGCCAGGCTGCTGAGAACCAGCTCTAGATCTCTGCTAGAGAGTCCTCCTTCTGCAGACATCACCAGTGTGTGGAGCCTGCCGCACACCCAC CCCCTGACAAACCACGGCCTTTACCTGTGTCTTTCGCTGTTTCCCGTGCGACCCATCCTGTGGGAGTGCCTCGTGGGCTGCCCCGGAGTTTGCCCCACGCTCAGCAGCGCCAATGGTGAAGATGACAA GATCCAAGACTTTTCAGGCATACCTACCCTCCTGCCACAGGACCTACAGCTGCATCCACTGCCGAGCTCACTTGGCCAATCACGACGAACTCATTTCCAAGTCCTTCCAGGGAAGTCAAGGGCGAGCC TACCTCTTCAACTCAGTAGTTAATGTGGGCTGTGGGCCTGCAGAAGAGCGGGTGTTGCTAACAGGACTACATGCCGTTGCAGACATTTACTGTGAAAACTGCAAAACCACTTTGGGCTGGAAATATGA ACATGCTTTTGAAAGCAGTCAGAAATATAAAGAAGGCAAATACATCATTGAATTAGCACACATGATCAAGGACAATGGCTGGGACTGACCTGATAGCATCCATCCGGTCCAGCATCCATGTGAATGCC ACCCAACTGAACATTCTACCCAAGCGTGAGAGAGTGACTGAACACACTCGGTTCCATCAACTTAGGGGCCTTGCCATCAGGGGTCATCCTCCCACCCTGACACCATCATTTTTGGTGACTGGCCTCTA AATCACTGTCTCTCTGTCTCTTTGCTTTGTATCTGTTTGTGAGTTGATCTTGGCTTCTCTGTTCTAGTGTTGGCTGAAAACAGTTACGAGCTGGAACGGACCCTTGGCTGCATGGTGGCAGCCCTACT TGAGGGGGGGTGGCCCTGCCCACATGAGAGCTGCCTGATGGCTGTCAGAACATCGGCATGTGAGCATGAGCAACAGAACAGGGGAACCTGGGAGTCCTAGGATTGGGGAAGGGGCAAGAGGGTGCAAT ATAACTGTACTGTTCTTGGAGACCTGCTAACTTAGGCTTGAAATAATTGACTCCTTCAAAAGGACAAAGAGAAAAAAAAATACCTCGTGGCTTTTGTTCTCTCTGATGATACACTCCTGCCCTAGCAT CAGATGTGCCAGGACAGCGGATTAGCACAAGAAGCATCCTTGATTCTAGCTGACAGGGCAGGACCCTAGCATTCTGGACCTGGACTGGAGAAGGTCCTGCTAAAGAGAATGGGGGGTGGGGAGTGTGT GTGTGTGTGGGGGGGGGTAAAGCTCAGTGGGTTTTAGTGATTCTGCCCTCTTTCCCCCCCGCCCCCTCCTGGGCAATCACCTTCTTGGTCTTCTTAACTGATTTAGGTTGCAGGAAAAGATACAAGAT GTGTGTGTCCCATTTAGCCCAAAGCACAGTAAAAATCGGTAATGGAGGAGAGCCAGGAGCTGGAGGCGTTGCTGTGGACCGGGAACTCCTGATAGCAAGCAGGAAATGTAAAAATGCAGAGGCAAGGT TCTGGGAGGAAGAGTTCAGATTGGAGCCAGTGAAGGCTTAGCACATCTTTCCTCATCCGATGATCAGTAGCTTCCATGGGACCAGCAATTCTTTGTGCACAACGTTTCTGAGTTTTGGGTTTTTTTTC CCCCCTCCAATTTTATCACCATAACCTGGAAACAAAGATCCAAGATTACACCTCCATTCTTAGCCCTGACTCTCCTATGTGGATAGACATCTTTTAACAGTGTGGTCCAGCAGTAGGGAGGGATTACA GATTCAATATTACTCCTTCACCCACCGCACGCACCCAAGCTTCCTTGAGTTAGGGTTGGGGAGGAAAGAAAAAATAATCCCTGTAAATCTCTTAAAATGAAAAAGAATTTATTGTGTGTAATCAACAC TGTGAAGGCTGTGTTGCATCAATCCAGCTATTATGTGGATTTGAAATCCTGTTTGAATCCATTTCGTTTATTTCTTAGGCAGAAGATAATGTTAAAATATGGGCATATTAGGTACTTCTCAGAATCTT GTTCTCTAGCTAGGCTGGTCCTACAGGAAAATTCACCTCTGAAAAAAAAAAGCCCAAGAAGAGAAGGAGCAAGAGTGAGCTCATGGAGATAAGAGCCTGTTGCCTGGCTAACCAATGCTAAAGCATCC CTCCAGGAACATTTTCCAGTCCACATCCCCAGCAGAACCAAATTCCATCAGGGAGAAAGCCGTGGTGGACACGGCTTTGTCCTGATCTGGAAATGGACAAATTGAGACTTGCCAGGGCAATAGGAAGT CAGCCAGCTCAGTAGACTGCCTGTCTTCTGGGACACAAAAGGATTCCTAGAAACAGAATTTTGTTCCTCAAGTCTGCTTGTCCTGGGCCCTGGAAGACTAGCTCTGCCCCACCCCCACCCCCACCCCA CTGCACAGCAAGGCCCACTGAGGGCCAGAAAAACTACCCGTGACTCCCAGGCTCAAGTGGTCAGTGACACACATTTCTCCAGTTTCACATTCCTAAGACTTGCCAGCTCCAAGCGTCATCCATTGTCC CCTCTTTATCCTGTTCGAAGATGTGGCCTTCATTAAAGATTTGATTAGACCCTTTGCTCAGGGAATACCTAGCTACATACACACTACAAGTCCTTTTTTTTTTTTTTTTTTTTAACTAGGGGGTGGGG ATCAAACCTAGGTAGTTTCTTAAAAACTAAAGTTGGTGACTTGCAGAAACTGGATCTATGGTGCCCTGGGTGGAGAAAGGGGCAGGGTCCTTGAACTACAAGTTTGGGGGTGGGACCAAAACTCATCA GGCTTCCCTTTGTGACGGTGAAACCAAAAGTGCTTCTTATGACCATTCTTAGCTCCACTCACAGCTTGTCTACCTAACACTTAGCAGTATTAGCGAGTCCTCAGCCCAGCGGGCGGCAGAGGCTCCTG CACCCAAGGCCTCTCTGGTCAGTTTTTTTTTTTTTCCTCACCAAATGATTGACTCAGCATAACCAAAGACCTCACCCCTTCACTCCACATAGGTTCAGGGAAAGGGAAGTCCTTTGGGTGACCTTGGG CAGGGGTGGGCAAGGACAGAAGAGGAGAAAGGGAAGGCCTGAGGGTACCTCAGCCGCCAGCTACCTTCACTTTGAAGTCTAGCTGACCAGCTCTCGCTCCACCTGCCCTGTGCCACTGTGGATGATGG GGCTATTGTCACCCTGGAATCCATCCACCCACCCCCGCCCCACCTCCGCATCTCCCCCCAGGCTGCTGATGAGTAAATCAACATGAGTCAAGTATAGCCAAGCTTGATGCTTGCATGCTCGCAGCGGG ACCTGGCTGAGTACCGACCACCCCAGCTCCTATGACAGATCATGTAGATAAAGTAAAGATCTCAGCTGGTGGATCAATGTGTACAAAAGAGGTGTCCCCTTTATAGTGGAGATTTCCAAGTATATACA TATATATCTATACAGTCGCTTGTGAAATATACTTTTGTAAATAATATTTAATTTTTTTAAATAATATATTTGGTGCTGTATTCTCAGACCCCCCTGAGAGCACTTTTATTTTCAATTCTATAGCTTCC TCTGTGTTATATTTTAAGGGAAAGGATAATCAACAAGACACTTTTTTTTTTCCTTTAAGGATCTGTAACTATAAAATGGATTGAGGCTTTAAAACATTTTTGCAGTTTTCTGTTTGCATTTTTACCCA GCAGAACAGACTAGTAAATTACCAGGTTGTGAATTGATACTTTCTTGCCCAGTATTGGCTAGAAAAGAAACAAGCTTAGTAGTAACAACTTCAGAGTAATTACTGTAGTTGGGAGAACTTCCAAGAAA TTGGAATAGACAGAGAGAGAGTGTGTGTGTGTTTCATTTTTCTGTTTCCTTTCCTACTGAGGACACTATGAACTACAGTTTACACCTTAGGCACAGAGTTTTCCCTCTGGTTTTCATGTGTGAGTGGA CCAAGAGCCCAAAGCAAGATTTTCTTTCCCTGAGGGTGGAGCCGCGGCCAGTTCCTCTTCTGTGTGTTCAGCTTCTACAGCCAGTGAAGCAAATCTGTGAAGAGAGCCAGCGTGAAGTCTGCGCTTCT GAGACGGGAGCAGCTCAGCCGCGCTCACATCCCGGGGCTCTGGCTGTTCTAGAAGCCGTGTCATATTAGAAGTTAACAAGTTCAGGTTTAAAAGGATAGTAATAGCTTTTTTTTTTTTAAAGTCAGAT TGCTTGGGGTTCAGGCAGAGGCTGGCAAATCAAATCTTGAACACACTTTTATATTAAAAAATCTGCCTCAATGGAAATACTAGTCCTATGACTGGGAAAGATTGTCTTTGAAATTGTGGTTGATTAAT AAAATTACTATACAGTCATGAAATGTACCCGAAAGGCGTTGTCCTCCTGGAGTTAGATCTGTCCAGCGTCTTACAGTGGTTTGGTGAGAACAGGAGTCAACTTCCTTTTCCCAGCCTGCAAAGACTGT GTACCATGGATTTGTCTGTCTGTCTGTCTGTCTGTGTTTACAAACTGTATTTGTTGGGTTTGGAATTGCTTTTGTTGTTACTTTTTTCTTCTTTTTTTGTTCCTTTCTTGGGTGGGAATTTTTTCCCC AGGTCACTTTGCTTCAGTAACAAAGGCAATTGTTTTTGAATAATTTGTCTTCACCTCCTTCCGGTATTTGTACATAATGATTCAGTATTAGTAAGAAGTGCGTTATTTCTGTCATTGCTGATCTGTGT TGGTGCTCATTTGAGAAAATAAAGTTTTCAAATACTAA
hide sequence
RefSeq Acc Id:
XM_011249316 ⟹ XP_011247618
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 11 86,855,736 - 86,884,629 (-) NCBI GRCm38 11 86,967,466 - 86,993,805 (-) NCBI
Sequence:
GCTGAGCCGATGGGATAGGCGCGGGGGCGCGTCTGTCACCCGGCAAGCCCCCAGCCCGGATTCG GAGGGATGCGGAGCGGCAGTGGCGGCGGCGGTGGCGGAGACTGTGGCTTTAAGAGCGCGCAGGGAGCGCTAGAGTCAGCCGTGCAGTCCTTCATCGCCAAGCACTCCGGAGAGCCCGGCGCTGGCCGG ACCGGGCAGCCTACCGCCAGGCTGCTGAGAACCAGCTCTAGATCTCTGCTAGAGAGTCCTCCTTCTGCAGACATCACCAGTGTGTGGAGCCTGCCGCACACCCACCCCCTGACAAACCACGGCCTTTA CCTGTGTCTTTCGCTGTTTCCCGTGCGACCCATCCTGTGGGAGTGCCTCGTGGGCTGCCCCGGAGTTTGCCCCACGCTCAGCAGCGCCAATGGTGAAGATGACAAGATCCAAGACTTTTCAGGCATAC CTACCCTCCTGCCACAGGACCTACAGCTGCATCCACTGCCGAGCTCACTTGGCCAATCACGACGAACTCATTTCCAAGGTTTTGTAGTCTCAGCTCCAGATGAGTGACAGCCAAGCGTTCCTCGTTAG CAGGCTGACCTGACTGGCACATGAAGGCTGCCCAGGCAACCAAGTCTCTGGTCACAGTATCTAACCCGAGGCCCTAGAACAGACCTCTGGGTTCTCTTCCAGGGTGCTTACTAACATAAGCTTGATGC CCAGAGCCCCCAGGGTGCTTACTCACCCATAAGCTTGATGCCCAGAGCCCCCAGGGTGCTTACTAACATAAGCTTGATGCCCAGAGCCCCCAGGGTGCTTACTCACCCATAAGCTTGATGCCCAGAGC CCCCAGGGTGCTTACTAACATAAGCTTGATGCCCAGAGCCCCCAGGGTGCTTACTAACATAAGCTTGATGCCCAGAGCCCCCAGGGTCCTGGCTGAACTCCCTCTTTTCCAACTACACTTAAGCTAGC CTTTTACTTTCCACCTATATCATATAATTCATCTTTTTTTGCAGATTTCCATTAAGTTTTTGGAGTAAACCTGGTAATTTGGATATGGGAGGTCATGTCAGTGGGAGAACTAGCCAGTCTCCTGGCGT TATATTTGAGTTGGCTCTGTCTCCCCTTCCACAACCTTTTTTTTGGGTAGACATTTCCAAAATAAGTGTTTCTATCTAGGGTGGACTCAGGCACCATTTTAACACAAGGGAGAAGTGTTCTGTGGTGT ATAAGAAGTCAAGGCTCCAAAAGAGTATGTTTTTTTGCATCTATTCTGTATTGAAAACTGCTATCTCCCTAACCCGTGTGACTCTTTAAGGTAAGTGGCTAGTCCTATGTCATACCAGTGGGAAGCTG AGACTCAAAAATATTGTTCAAGGTCTCAACATGGAGGTTAAGAAAAGTGATTAGTGTCTGCTGGTGTTCAGTCAGGATTTCTTGACAAGGCCTGAAGAGATGGCTGAAGCTGGACATGTGGAGATGGC AGTGGCATCCAGGGTCGCATCTGCAGGCGTGCAGGGCGTTGCTTCATTTTAGCCAGGAGACACTAGCAGTGTCTGTCCCTTGAGCATTCTGGTAAAGGCATCTCACGCCTCTGCCAAGGGCTGACCCC TCCTTGCCTCCTCTCCTCCCTCGTCCTTCTGTGGGTCCTCTGATCAGAACTTGACCGGCCCATGACAGCAGCTCAGTAAATGGACAGATGATGTTTGAGCCTTGGGAGAAGACGAGGAGGAAGCAGAG AAGGCTGCATTGCCTTCATGTTCTCCCATACCCATTCTGGGGCTCACAAGTCTAAGCCAAAGTCAGCAGAGGCTTTGGTTTCATTGGCTACAGCCAGCGCGCGCACAGATGGGGTGCATTAGAGATGG ATGATTTAAGGAGTTGGGTGAAATGCCTGACTGGGGAAAGAGCGAGGGAACTGTGCTTGGCATTGTACAAAGATTCCTTTATTCTGCTGCACAGCCACCCCCGGCATTAAATAATCTATACATTCTTA TGCACGTCCGCTTAATGGAAAGATCGTTGCCTCGGCCCCCTCCTTGGAAAAATGGGCCTTTCTTTTCATGCCCACCCCCCTCCATTTAGGAAAGTTCAAGGAGAGAATGTCCCTCCTGTTCCCCTCTT GACTTAATCTCCTGTGTGGTTTCTGAGTCTGCCCAGTGGGAGTGGAGAGCTGGACACCAGAAAGTCAGGGCGGGAACCCCAGTGCAATTAATGAGGCTTTGTACTGGTAATAGGGTCTTTAGTCAGAG AGCTGGATGTTTGGGGAACAAAAAACAAATAAAGTGAGCCTGCCTTCCTGATGGAGAGAGACAGGCAAAGGTCCAGAGGAGGGAGGGGGTGTCTAGAATGAACAGGGGACTTCAGCATCCCTTCCAAT CCGCATGGCTAGGCCACCACGGGAATGCTACATTGTAAAGTTTTAACAGTTGAGTGTGTTGATTGGGCTGGTGGAAAGCTCTGTGCAGGGCTTGCTTCCTGCCCTGCTCACTTTACATACCCAGGAGC TTCAGTTGCCAGCAATCAGCTGCCCAACCCCCCAACCCCCCCAGTCTCAGTTTCTTACAAAATGGGCAAAATGGTATCCTCTGTGATTGTAGTGCCTGATTCTGGGGGTGGGTGGGGGTGGGGCTGGA ATCACCAGATTGTCAACAGAATGGCTCCTAAACAAGCAAGTTTACCTCTCATTCATCTGGAGGCCGGAAAACCCCAGATTTAGAAACTTGGCAGACTCGGTGTCTCAAGGTTTTACGTTCCAGTGCAC ACATCCATCCCATGTTACTGTGTGGCCTTACGGGGGAGGGGCAAAAGATCTTCCTCTGGCTTATTTCTTTATTATCATATTTTGTGTATATGCTTTGAGACAGTCTTGTGGAGTTGCCCCTGTCTATG GTCTTTAACTGCTGGGCCTTAAGAGGTCTTTCTGCTTCCAGGTGTACAGGGCATATATGTGCCACTGTGCTTGGCTGTTCTGGCTCCTTTATACTGACAATAATCTCACTTCCGAGGGCTCTGCCTTC ATGGCCCAATAATCTATTTCAATACGATTGGGGGATGGGTAGACTCTGAGACCATGTGAGGTGGCAGGTAACTAGCATTTAGTGTGTGCCTCTGGCTGCTGTCTCCATGGCAAGGCATACCTCACTGG GAAAGGAGCAGCCTCACCTCATTGCGTTGCCACACAGCTCAGATGCGGATCAGGGTGGATTGTGGACGACAAAGGTGTTTGCAGTATAAAGTAGTTCCATTTCCTCTCTTGGTCTTGTTATTCCAAAT GTAAAGTGGGGAGGTTGGAGGGAATATTCAGCTTGGGTTTTCCATCAAGACCCAGTGCATAGGCATTGGATGTAGGGAAAGGACAGTGATAGCCCTGTATGTCTAAGGCATACACGTTCCGGCCTGTG GGAGGGGAGACTTTTGAATTGATAATAGAACCATCTAGAGAATGTGCTGAGGCGTTCCACGATCTCTTTCTTGAGGGTGGTATGGTCTACATGCTGGGCTGTTTGTCTGCAGAGGTATTTTGAGTTGG CATGAAGAATTGCTTGCACCATTGTTCTTAATGTTGCCAGCCCCGGCCAGCAAAAAACAAAAACAAAAACAAAAAAAACCACACTTGGATTATAAAATAATAATGGCTCCCGCCAGATCAGTGAGTCC TGCCTCAGCCTCCCAAGTAGCCCAGGTTTACAGGCCGTACCACCAAGTGCAGCTGTGTGGAGACCTCCCCACTTGCTGTCCTCCTGCCAGTCCTAAGCCGAACAGCAGGGTGTTTGGGAATTTGTGGC TTCATTTCAAGACTTGATCCTTATCGGAAGGGCGGGCATTGTGGGAGGCTGTCAAGTGGGTGTCCAGGGCAGGTGGAAAGAAGAAATATTCGGCTCACCACCCAACCTACTTGTGACTGTTTGGTTAG ATCTTTGGGCCTGATTATTTTCTAGAGACAGAGGCGCTCCGGAACTGCAAGGCTGTCTACTCTTGGTCAAGAAACAGGTCAGAGCGAGGCAGGAAAGCAGCCTTAGGTCACACTGCCTCTGAACCAGG GACCTCTGTCTCCGCCTGGGCCATGTTCTGGGTGAGGAGCCCTGAGCAAACTTGCCTTCTGGCTCCTGGCAGTACTTTAGAGGCTAGGAACTTGGGCAGTGGTTTATTTTGTTCCTCGTGGGGTTCCT TGGGCTGGCTGTGGTGGCATTTGGACTCTTTTTTCCTGCCAAGAGATTAGATATAACATTGCTTAGAGAGTCAGGAGGGCACCTGTGCTACAGCTGTATTGACCGTGCAGCTGCCACAGGGCTAACCT GCTCTCGTTTCCCACCTGTGCCTTTGAGCCATAGTGTTGCGGTTCCCAGCAAGCCTTTGACCTCTCGCTCCAGTGCAGTGGCTTATAGGTCACAGACGTGGTGGGGTGCTGATGTGGCAGCACAGAGA TATGCCCCATCGTGCTGACCGTCCTGTCAAGGTGGTCTTTGCTTCTCTTAGTTTCTTCGGTCCATCATTTTGCTGCTTTTAATAAACACTCTAAAGCAGATGTTCTCAACCTTCCCAATGCTGTGACC CTTTAATACAGTTCCTCATGTTGTGGTGACAAGTTATTTCCGTTGCTACATGCATAACTTGTAATTTTGCTACTGTTATGAATCATAGTGTAAATGTCTGATATACAGGATGGTCTTAAGGCAATCCT TAAAAGGGTCATTGAGCCCTCAAAGGGTTACAACCCATAGGTTGAAAACCACTGCTCTACAGTATTAATGTCCTGATACTAGCATGTAGGAAGTCCTAAGTTAGATCCCCAGAACCACAGATACATGT AATTCCAGCATTAGGGAAATAGAGACAGAAGGATCAGGAAGTTCAAAGGTCACCCTTGGCTACGTAGCAAGGTTGAGGCCAACCTGAGCTACATAAAGACCTGTTTCAAAAAGAAGAAAAAAATCACA TGAAGAATCTAGAAGCATAGAAAATGCCTGCATTTCCTTTTCTTTAGGTAAAACTAAAAGCAGAGTAGACATTGGGCTGTCACCACAGCTCTGATATGTGCTTCCACAGAAGGTAGTACTGCACAAGG GGCATTTCCATATAACACTCCTCACCAACTAGTCCTTTAGTGCCTGTCTCTAGCTTGCAAAGTATGTTGAACTTGAGTTTGAGTGTGTATTTGTCTGAATGTTTATATACCACATGTGTCTGGTGCCT GAGGAGGGCCCTGGATCCCTGGCAGCTGGAGTTATGGTCCCGAGCCACCATGTGGGTGGCTCTCTCTGAGCCATCTCTCCAGCTCTCCCCCTCCCCCCTTTTAAAAAATTCAATAGATGTATGCTCTA TTTGGTTTAAAGAAAAAAAACACTGAAGTAAAATTAATATTTCTATTGACAATGGGGAGGAAACAAAGGATTGAAGTTAAATCTATAAATAAATATCTAGCTCATAAAAGTTTTTGAGTACCGCGGCG TCAGTTGTATCGCAGTAATTAAAAGTCGCTCAGGGACAGGTGGTTGAACCATTGCTGTATGACCTCGATGAAGGTTTTGTGACTTGAGTCTTTGTGTTCTCCTTTTTTCTTTTTGAGGTTTCTTCCCC CAGCCCACCAACTCTCCATATGTCTGTCTGTCGGTGTGTCTGTCTGTCGGTGTGTCAGCGACTACGTACCTGTGCTTCTGGGTGGAGGCCAGAGGACTTCAGTATCATTCCTCAGCCTCTTGGCCACT TTGTCCCTTACAGGCCTGTAACTCATTGATTAGGCTTGGTTGACTGGCTGACTGGTTGGCCAACGAGTCCCAGGAAATCTCCCTGCCTCTGCCTCCCGGATGCTGGAATTACAAGTGCATGCCATCAC ACCTGTCTTATTTACTTTTCCACACCCAACCCCTCCCCCCTTTACATCCCCTTTTAAAAATATGAATTGTGAGGTTCAAGCTCAGGTCCCCCTGCCTGTGCAGCAAGCCTTCTATCTTCCCAGCCTGA ATGTCTTAAAGGGATGTGTGTGTCTGTGTGTGTCTGTGTGTGTGTGTGTCTCAGGTAAAAGAAATCTGAACAGAAAATTCTTTGAACCACATGACTTGGTTGGATTGCAGCACTTCTTGGTAAAATGC TATTTGGAGCCTGCAAACGCTGTGCTGTGTGGTGTCTTTAGGATGAAGAAGCAAGAAACTTTCTCAGGGGTGTTCATGTTTGGGAACAAGACTTAGTTTTAAGCGTGTCCCGCTTGCTCCTGTCCATT TGCTCTTCCTGTGGCCTCCGGAATGATAAGGCTATCGCATTGCTGGTTTGGCTGCTGAACTTGGAGGACCTGACCAGAGTCTAAGTCCTTGTACATTTTGTTCAATATTTTATTTCTTTTGTTTAGTC CCTTCCCCCCTCTCTAAAAACAGTTTTGATTGTCAGTGTTGACATGGGGTACTCTGTCTTAGCCTGCCTGCCACCAGGACTATAAGAGTAGAATCCCAGACCCAACCTGAATAATACTGCTTGATCTA GGGGCTAGGGATGAGGAGATGAAGCCAGCATGATTCTTGCAGTGAGGGCCAGTGATCTCAGTAGGTAAGACATGGGAGAGCAAGGCCCACTGCGGAGGTCAGGAGGATGTTATTAATGAGACTGGCTT GGGTATCATTAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NP_001005341 ⟸ NM_001005341
- UniProtKB:
Q65Z95 (UniProtKB/Swiss-Prot), Q0VA86 (UniProtKB/TrEMBL)
- Sequence:
MVKMTRSKTFQAYLPSCHRTYSCIHCRAHLANHDELISKSFQGSQGRAYLFNSVVNVGCGPAEERVLLTGLHAVADIYCENCKTTLGWKYEHAFESSQKYKEGKYIIELAHMIKDNGWD
hide sequence
RefSeq Acc Id:
XP_011247618 ⟸ XM_011249316
- Peptide Label:
isoform X1
- Sequence:
MRSGSGGGGGGDCGFKSAQGALESAVQSFIAKHSGEPGAGRTGQPTARLLRTSSRSLLESPPSADITSVWSLPHTHPLTNHGLYLCLSLFPVRPILWECLVGCPGVCPTLSSANGEDDKIQDFSGIPT LLPQDLQLHPLPSSLGQSRRTHFQGFVVSAPDE
hide sequence
Ensembl Acc Id:
ENSMUSP00000158888 ⟸ ENSMUST00000238921
Ensembl Acc Id:
ENSMUSP00000018571 ⟸ ENSMUST00000018571
RGD ID: 6822482
Promoter ID: MM_KWN:9040
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Brain, ES_Cell, Kidney, Liver, Lung, MEF_B4
Transcripts: NM_001005341
Position: Mouse Assembly Chr Position (strand) Source MGSCv36 11 86,806,924 - 86,807,424 (-) MPROMDB
RGD ID: 8676030
Promoter ID: EPDNEW_M16046
Type: initiation region
Name: Ypel2_1
Description: Mus musculus yippee like 2 , mRNA.
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Mouse Assembly Chr Position (strand) Source GRCm38 11 86,993,722 - 86,993,782 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2017-10-31
Ypel2
yippee like 2
yippee-like 2 (Drosophila)
Symbol and/or name change
5135510
APPROVED